Rheumatoid Arthritis
News from the FDA/CDC
FDA approves Idacio as eighth adalimumab biosimilar in U.S.
Data for Idacio (adalimumab-aacf) showed safety, efficacy, and immunogenicity similar to Humira.
From the Journals
RA risk raised by work-related inhaled agents
Exposure to detergents, dusts, and other chemicals in the workplace could be putting genetically susceptible people at risk of rheumatoid...
From the Journals
Randomized trial finds DMARD therapy for RA has a beneficial effect on vascular inflammation, CV risk
Receipt of a tumor necrosis factor inhibitor or triple therapy for rheumatoid arthritis yielded an equally beneficial effect for reducing vascular...
From the Journals
Vaccination cuts long COVID risk for rheumatic disease patients
Although it’s possible the higher proportion of Omicron cases in vaccinated patients accounted for lower rates of long COVID, differences in...
From the Journals
Skinny-label biosimilars provide substantial savings to Medicare
The estimated savings to Medicare during 2015-2020 that resulted from competition with five of the first-to-market biosimilars with skinny labels...
Feature
Wide variance described in lab monitoring of conventional synthetic DMARDs
“The take-home message of this study is that everyone is doing something different, which means that the system likely has a lot of low-value...
Guidelines
New ACR vaccination guideline: Take your best shot
Vaccinate patients with rheumatic and musculoskeletal disease against flu and other vaccine-preventable disease whenever possible, experts say.
From the Journals
Celiac disease linked to higher risk for rheumatoid arthritis, juvenile idiopathic arthritis
“I hope that our study can ultimately change clinical practice by lowering the threshold to evaluate celiac disease patients for inflammatory...
Conference Coverage
StopRA trial: Hydroxychloroquine doesn’t prevent or delay onset of rheumatoid arthritis
A randomized clinical trial found that hydroxychloroquine was no more effective than placebo at preventing or delaying onset of rheumatoid...
Conference Coverage
Opioids increase risk for all-cause deaths in RA vs. NSAIDs
The incidence of all-cause mortality was higher for patients with rheumatoid arthritis who started on opioids rather than NSAIDs for pain control...
Feature
Doctors urge screening for autoimmune disorders for patients with celiac disease
At least in some cases, people with one autoimmune disorder should be tested for others, celiac disease specialists say.